Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fish parvalbumin allergen is a highly stable, low-molecular-weight calcium-binding muscle protein (usually 10–12 kDa, 108–113 amino acids) prevalent in the white muscle of most bony fish species. Parvalbumins belong to the EF-hand protein family and exist as two phylogenetic lineages: alpha and beta; only the beta-type is considered a major food allergen in fish. Parvalbumin functions physiologically as a Ca2+ buffer involved in muscle relaxation, but pathologically, it is the primary allergen causing fish-induced food allergies via IgE-mediated immune responses. The allergen is characterized by its strong resistance to digestion and heat, as well as a high clinical cross-reactivity among fish species due to conserved IgE-binding epitopes. Clinical manifestations include oral allergy syndrome, abdominal pain, urticaria, asthma, and anaphylaxis in allergic individuals. Diagnostic tests often measure parvalbumin-specific IgE as a biomarker, and the molecule is a key focus in risk management for allergic consumers. Parvalbumin is not a therapeutic drug target but is important in allergy diagnosis, food safety, and forensic fish identification.
None applicable for drugs. Parvalbumin as an allergen primarily acts by binding IgE antibodies in allergic individuals, leading to immune cell activation and allergy symptoms. If considered for immunotherapy, mechanism would be immune tolerance induction to parvalbumin.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fish parvalbumin allergen (Parvalbumin).